Phosphoenolpyruvate carboxykinase (PEPCK) deficiency is a gluconeogenesis disorder that results from impairment in the enzyme PEPCK, and comprising cytosolic (PEPCK1) and mitochondrial (PEPCK2) forms of enzyme deficiency. Onset of symptoms is neonatal or a few months after birth and includes hypoglycemia associated with acute episodes of severe lactic acidosis, progressive neurological deterioration, severe liver failure, renal tubular acidosis and Fanconi syndrome. Patients also present progressive multisystem damage with failure to thrive, muscular weakness and hypotonia, developmental delay with seizures, spasticity, lethargy, microcephaly and cardiomyopathy. To date, there is no conclusive evidence of the existence of an isolated form of this disorder.
Comprehensive, easy-to-understand information about this condition
Checking for content...
fructose-1,6-bisphosphatase deficiency
MONDO:0009251
phosphoenolpyruvate carboxykinase deficiency, mitochondrial
MONDO:0009864
phosphoenolpyruvate carboxykinase deficiency, cytosolic
MONDO:0009866
pyruvate carboxylase deficiency disease
MONDO:0009949
hyperammonemic encephalopathy due to carbonic anhydrase VA deficiency
MONDO:0014332
glycerol kinase deficiency, infantile form
MONDO:0017294